SlideShare a Scribd company logo
1 of 5
Download to read offline
Next-Generation Superfruits
Report Details:
Published:September 2012
No. of Pages: 90
Price: Single User License – US$2875




This report examines the emerging market of superfruits within the global food and drinks market,
analyzing data from four metrics: product launches, patent applications, health claim applications,
and clinical trial data. This will enable manufacturers to assess the emerging trends and growth
opportunities within the superfruit food and drinks landscape.
Features and benefits
•Use patent application data to see which superfruits are provoking the most interest in terms of
 research and what is being deemed patentable.
•Use product launch data to identify the target areas for existing superfruit-based products.
 Understand the product breakdown by category.
•Assess EFSA's opinions and understand what types of claims are being made about which
 superfruits.
•Identify three up-and-coming superfruits as “ones to watch” in the future.
Highlights
Blueberry and pomegranate are the most popular superfruits in new food and drink launches. But
novel fruits are gaining ground, with chokeberry, jujube, and seabuckthorn being notable
examples. Over 400 new food and drink products containing seabuckthorn were launched in
2009–12, the majority of which hit shelves in Russia, Germany, and France.
A high proportion of health claims involving superfruits have been specifically about antioxidants,
with over one in 10 claims submitted to EFSA addressing antioxidant properties. Although many
superfruit ingredients have been lauded for their cellular protection properties, only acerola is
associated with an endorsed health claim by EFSA.
According to the Cochrane Library, a significant 63% of clinical trials undertaken on superfruits in
the period 2009 to 2012 were able to establish a cause and effect relationship. This should prompt
further testing in future to establish the positive roles superfruits play in managing certain health
conditions.
Your key questions answered
•What are the more unusual superfruits that have potential to be successfully applied to food and
 drinks products?
•What health claims are being made about superfruits and how will these impact food and drinks
 players?
•What clinical trials are being undertaken on superfruits and how can these be useful to food and
 drinks companies?
•What patent applications have recently been filed on these superfruits and what will be the impact
 on their FMCG usage?
•How will regulations impact the sale of these superfruits in global markets?


Get your copy of this report @
http://www.reportsnreports.com/reports/195677-next-generation-superfruits.html

Major points covered in Table of Contents of this report include
Table of Contents
About the author
Disclaimer
EXECUTIVE SUMMARY
The product launch landscape
The patent landscape
The health claims landscape
The clinical trials landscape
Introduction
What is this report about?
Defining superfruits
Methodology
Report structure
The product launch landscape
Summary
Introduction
Leading superfruit ingredients in NPD
Novel superfruit ingredients in NPD
Chokeberry
Jujube
Seabuckthorn
New product category analysis
Claims analysis in new product launches
Anti-infective
Cardiovascular
Digestive health
Metabolic disorders
Conclusions
The patent landscape
Summary
Introduction
Superfruit patent applications
Tier one
Tier two
Tier three
Patents by therapeutic health area
Conclusions
The health claims landscape
Summary
Introduction
EFSA now has stricter controls on functional food claims
Analysis of superfruit health claims from EFSA
Scientific opinion
Leading therapeutic areas of claim submissions
Conclusions
The clinical trials landscape
Summary
Introduction
Existing clinical evidence for superfruits
Most popular therapeutic areas for superfruit clinical trials
Conclusions
Conclusions
Key superfruits
Current market landscape summary
Key targeted therapeutic areas
Superfruits: ones to watch
Mangosteen
Papaya
Seabuckthorn
Conclusions
Appendix
Methodology
Glossary/abbreviations
Bibliography/references
List of Tables
Table: Superfruits covered in this report
Table: Leading superfruits in new food and drinks, by percentage of superfruit launches, 2009–12
Table: Leading superfruits in new food and drinks, by percentage of the 30 superfruits analyzed in
this report, 2009–12
Table: Targeted therapeutic areas by health claims on new product launches (%), 2009–12
Table: Patent applications in 2010 related to tier one superfruits
Table: Acerola related patent applications, 2005–11
Table: Tier three superfruits: No patent applications related to food and drink
Table: Digestive health and metabolic therapeutic areas related to superfruit patent applications
Table: EFSA negative opinions for superfruit health claims, 2011
Table: Targeted therapeutic areas by health claims submitted to EFSA, 2009–12
Table: Superfruit status by clinical trials, 2009–12
Table: Targeted health areas of clinical trials, 2009–12
Table: Future opportunities in superfruits as indicated by successful clinical trials, 2009–12
Table: Patent applications for mangosteen, in food and drinks, 2005–12
Table: Health claim applications for mangosteen, 2009–12
Table: Clinical trials involving mangosteen, 2009–10
Table: Patent applications for papaya, 2001–12
Table: Health claim submissions for papaya, 2009–12
Table: Patent applications for seabuckthorn, 2000–12
Table: Health claim submissions to EFSA for seabuckthorn, 2009–12
Table: Clinical trials for seabuckthorn
Table: Alternative names for superfruits
List of Figures
Figure: Total oxygen radical absorbance capacity value, raw fruits
Figure: "High antioxidants" is a leading health claim found on US food products, and has a strong
association with superfruits
Figure: Proportion of US consumers that say that they are familiar with specific superfruits
Figure: Leading countries for superfruit food and drink launches by SKU, 2010–12
Figure: A selection of blueberry-flavored products that have recently been launched
Figure: A selection of pomegranate-flavored products that have recently been launched
Figure: Food and drink launches containing chokeberry, 2009–12
Figure: Chokeberry/aronia-flavored healthy indulgent foods
Figure: Products containing jujube
Figure: Food and drink launches containing jujube, 2009–12
Figure: A selection of seabuckthorn-flavored products
Figure: Food and drink launches containing seabuckthorn, 2009–12
Figure: New product launches by industry and category (%), 2011
Figure: New product launches by industry and category (%), 2011
Figure: Superfruit tea and coffee launches
Figure: Raspberry hazelnut vinaigrette and superfruit berry varieties of Wish Bone salad dressing
Figure: Percentage of consumers who frequently consume products described as the following
Figure: A word cloud showing superfruit patent applications: the bigger the word, the more patents
the superfruit has had
Figure: Tier one superfruits: number of patent applications related to food and drink
Figure: Tier one superfruit patent activity by year, 2005–11
Figure: Tier two superfruits: Number of patent applications related to food and drink
Figure: Tier two superfruit patent activity by year, 2005–11
Figure: Patents by therapeutic area
Figure: Health claims related to superfruits submitted to EFSA, 2009–12
Figure: Classification of superfruits by number of health claims submitted to EFSA, 2009–12
Figure: Targeted therapeutic areas by health claim submissions, 2009–12
Figure: Superfruits supported by clinical trials data (%), 2009–12
Figure: Targeted therapeutic areas of clinical trials (%) ,2009–12
Figure: Future of superfruits as indicated by manufacturing, research, health claims, and patents
Figure: The future of the leading superfruits as indicated by health claim, patent and clinical trial
activity
Figure: Superfruits by health claim submissions and clinical data, 2009–12
Figure: Superfruits by patent applications and to clinical trial data
Figure: Superfruits by manufacturer interest and clinical data
Figure: Key targeted therapeutic areas by superfruits
Figure: Mangosteen NPD activity and patent, health claim, and clinical trial submissions
Figure: Top five categories for new mangosteen food and drink launches, 2009–12
Figure: Selection of mangosteen-flavored juice and ice cream
Figure: Leading countries for mangosteen food and drink launches by SKU, 2009–12
Figure: Papaya NPD activity and patent, health claim, and clinical trial submissions
Figure: Leading countries for papaya food and drink launches by SKU, 2009–12
Figure: Top five categories for new papaya food and drink launches, 2009–12
Figure: A selection of juices and fruit products containing papaya
Figure: Seabuckthorn NPD activity and patent, health claim, and clinical trial submissions
Figure: Leading countries for seabuckthorn food and drink launches by SKU, 2009–12
Figure: Top five categories for new seabuckthorn food and drink launches, 2009–12
Figure: Selection of seabuckthorn jams and jellies, including Mondo Berry


Contact: sales@reportsandreports.com for more information.

More Related Content

Viewers also liked

Zeiterfassung und BDE für BueroWARE ERP
Zeiterfassung und BDE für BueroWARE ERPZeiterfassung und BDE für BueroWARE ERP
Zeiterfassung und BDE für BueroWARE ERPsoftenginegmbh
 
Chinese Markets for Propene
Chinese Markets for PropeneChinese Markets for Propene
Chinese Markets for PropeneReportsnReports
 
Enroll America's Uninsured Landscape Findings for 2015
Enroll America's Uninsured Landscape Findings for 2015Enroll America's Uninsured Landscape Findings for 2015
Enroll America's Uninsured Landscape Findings for 2015Enroll America
 
GROWtalks - 10 Metrics You Need to be Tracking - Neil Patel KISSmetrics
GROWtalks - 10 Metrics You Need to be Tracking - Neil Patel KISSmetricsGROWtalks - 10 Metrics You Need to be Tracking - Neil Patel KISSmetrics
GROWtalks - 10 Metrics You Need to be Tracking - Neil Patel KISSmetricsDealmaker Media
 
Helping Consumers Get Covered and Stay Covered - Initial Lessons Learned From...
Helping Consumers Get Covered and Stay Covered - Initial Lessons Learned From...Helping Consumers Get Covered and Stay Covered - Initial Lessons Learned From...
Helping Consumers Get Covered and Stay Covered - Initial Lessons Learned From...Enroll America
 
3. Nürnberger Socialbar - Überblick Web 2.0 Events in Nürnberg
3. Nürnberger Socialbar - Überblick Web 2.0 Events in Nürnberg3. Nürnberger Socialbar - Überblick Web 2.0 Events in Nürnberg
3. Nürnberger Socialbar - Überblick Web 2.0 Events in NürnbergBluepingu e.V.
 

Viewers also liked (9)

Pet Care in Austria
Pet Care in AustriaPet Care in Austria
Pet Care in Austria
 
Tobacco in Macedonia
Tobacco in MacedoniaTobacco in Macedonia
Tobacco in Macedonia
 
Zeiterfassung und BDE für BueroWARE ERP
Zeiterfassung und BDE für BueroWARE ERPZeiterfassung und BDE für BueroWARE ERP
Zeiterfassung und BDE für BueroWARE ERP
 
Just Weekend - Vrseţ, Serbia 2011 - Ilie Rădoi
Just Weekend - Vrseţ, Serbia 2011 - Ilie RădoiJust Weekend - Vrseţ, Serbia 2011 - Ilie Rădoi
Just Weekend - Vrseţ, Serbia 2011 - Ilie Rădoi
 
Chinese Markets for Propene
Chinese Markets for PropeneChinese Markets for Propene
Chinese Markets for Propene
 
Enroll America's Uninsured Landscape Findings for 2015
Enroll America's Uninsured Landscape Findings for 2015Enroll America's Uninsured Landscape Findings for 2015
Enroll America's Uninsured Landscape Findings for 2015
 
GROWtalks - 10 Metrics You Need to be Tracking - Neil Patel KISSmetrics
GROWtalks - 10 Metrics You Need to be Tracking - Neil Patel KISSmetricsGROWtalks - 10 Metrics You Need to be Tracking - Neil Patel KISSmetrics
GROWtalks - 10 Metrics You Need to be Tracking - Neil Patel KISSmetrics
 
Helping Consumers Get Covered and Stay Covered - Initial Lessons Learned From...
Helping Consumers Get Covered and Stay Covered - Initial Lessons Learned From...Helping Consumers Get Covered and Stay Covered - Initial Lessons Learned From...
Helping Consumers Get Covered and Stay Covered - Initial Lessons Learned From...
 
3. Nürnberger Socialbar - Überblick Web 2.0 Events in Nürnberg
3. Nürnberger Socialbar - Überblick Web 2.0 Events in Nürnberg3. Nürnberger Socialbar - Überblick Web 2.0 Events in Nürnberg
3. Nürnberger Socialbar - Überblick Web 2.0 Events in Nürnberg
 

Similar to Next-Generation Superfruits

World Market for Clinical Nutrition Products (Infant, Parenteral and Enteral ...
World Market for Clinical Nutrition Products (Infant, Parenteral and Enteral ...World Market for Clinical Nutrition Products (Infant, Parenteral and Enteral ...
World Market for Clinical Nutrition Products (Infant, Parenteral and Enteral ...ReportsnReports
 
Omega-3 : Global Product Trends and Opportunities
Omega-3 : Global Product Trends and OpportunitiesOmega-3 : Global Product Trends and Opportunities
Omega-3 : Global Product Trends and OpportunitiesMarketResearch.com
 
Abdullah al hamdan e scan
Abdullah al hamdan e scanAbdullah al hamdan e scan
Abdullah al hamdan e scanBadr MSDK
 
Consumers and Sustainability: Over-the-Counter Medications and Supplements
Consumers and Sustainability: Over-the-Counter Medications and SupplementsConsumers and Sustainability: Over-the-Counter Medications and Supplements
Consumers and Sustainability: Over-the-Counter Medications and SupplementsMarketResearch.com
 
The Future of Probiotics in Functional Foods and Beverages
The Future of Probiotics in Functional Foods and BeveragesThe Future of Probiotics in Functional Foods and Beverages
The Future of Probiotics in Functional Foods and BeveragesDatamonitor Consumer
 
Sugar, Sugar Substitute, and Sweetener Trends in the U.S., 3rd Edition
Sugar, Sugar Substitute, and Sweetener Trends in the U.S., 3rd EditionSugar, Sugar Substitute, and Sweetener Trends in the U.S., 3rd Edition
Sugar, Sugar Substitute, and Sweetener Trends in the U.S., 3rd EditionMarketResearch.com
 
Nutraceuticals Market: Global Forecast 2015 - 2020
Nutraceuticals Market: Global Forecast 2015 - 2020Nutraceuticals Market: Global Forecast 2015 - 2020
Nutraceuticals Market: Global Forecast 2015 - 2020IMARC Group
 
2Calendar No. 242 114TH CONGRESSSENATE .docx
2Calendar No. 242 114TH CONGRESSSENATE            .docx2Calendar No. 242 114TH CONGRESSSENATE            .docx
2Calendar No. 242 114TH CONGRESSSENATE .docxtamicawaysmith
 
Us biosimilars market opportunity & clinical pipeline analysis
Us biosimilars market opportunity & clinical pipeline analysisUs biosimilars market opportunity & clinical pipeline analysis
Us biosimilars market opportunity & clinical pipeline analysisRajesh Sarma
 
Download Us biosimilars market opportunity & clinical pipeline analysis
Download Us biosimilars market opportunity & clinical pipeline analysisDownload Us biosimilars market opportunity & clinical pipeline analysis
Download Us biosimilars market opportunity & clinical pipeline analysisKuicK Research
 
Orphan Drug Report
Orphan Drug ReportOrphan Drug Report
Orphan Drug ReportBill Smith
 
Global Nutraceuticals Market | Functional Food | Industry Analysis, Size and ...
Global Nutraceuticals Market | Functional Food | Industry Analysis, Size and ...Global Nutraceuticals Market | Functional Food | Industry Analysis, Size and ...
Global Nutraceuticals Market | Functional Food | Industry Analysis, Size and ...IMARC Group
 
The Clinical Trials Business
The Clinical Trials BusinessThe Clinical Trials Business
The Clinical Trials BusinessReportLinker.com
 
2014 Profile: Biopharmaceutical Research Industry
2014 Profile: Biopharmaceutical Research Industry2014 Profile: Biopharmaceutical Research Industry
2014 Profile: Biopharmaceutical Research IndustryPhRMA
 
Group4padgett&becoatm6a1
Group4padgett&becoatm6a1Group4padgett&becoatm6a1
Group4padgett&becoatm6a1Stephen Padgett
 
Group4 padgett&becoatm6a1
Group4 padgett&becoatm6a1Group4 padgett&becoatm6a1
Group4 padgett&becoatm6a1Henry Becoat
 
Challenges for drug development jsr slides aug 2013
Challenges for drug development jsr slides aug 2013Challenges for drug development jsr slides aug 2013
Challenges for drug development jsr slides aug 2013CincyTechUSA
 
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013ReportLinker.com
 

Similar to Next-Generation Superfruits (20)

World Market for Clinical Nutrition Products (Infant, Parenteral and Enteral ...
World Market for Clinical Nutrition Products (Infant, Parenteral and Enteral ...World Market for Clinical Nutrition Products (Infant, Parenteral and Enteral ...
World Market for Clinical Nutrition Products (Infant, Parenteral and Enteral ...
 
Omega-3 : Global Product Trends and Opportunities
Omega-3 : Global Product Trends and OpportunitiesOmega-3 : Global Product Trends and Opportunities
Omega-3 : Global Product Trends and Opportunities
 
Abdullah al hamdan e scan
Abdullah al hamdan e scanAbdullah al hamdan e scan
Abdullah al hamdan e scan
 
Consumers and Sustainability: Over-the-Counter Medications and Supplements
Consumers and Sustainability: Over-the-Counter Medications and SupplementsConsumers and Sustainability: Over-the-Counter Medications and Supplements
Consumers and Sustainability: Over-the-Counter Medications and Supplements
 
final ppt
final pptfinal ppt
final ppt
 
The Future of Probiotics in Functional Foods and Beverages
The Future of Probiotics in Functional Foods and BeveragesThe Future of Probiotics in Functional Foods and Beverages
The Future of Probiotics in Functional Foods and Beverages
 
Sugar, Sugar Substitute, and Sweetener Trends in the U.S., 3rd Edition
Sugar, Sugar Substitute, and Sweetener Trends in the U.S., 3rd EditionSugar, Sugar Substitute, and Sweetener Trends in the U.S., 3rd Edition
Sugar, Sugar Substitute, and Sweetener Trends in the U.S., 3rd Edition
 
Nutraceuticals Market: Global Forecast 2015 - 2020
Nutraceuticals Market: Global Forecast 2015 - 2020Nutraceuticals Market: Global Forecast 2015 - 2020
Nutraceuticals Market: Global Forecast 2015 - 2020
 
2Calendar No. 242 114TH CONGRESSSENATE .docx
2Calendar No. 242 114TH CONGRESSSENATE            .docx2Calendar No. 242 114TH CONGRESSSENATE            .docx
2Calendar No. 242 114TH CONGRESSSENATE .docx
 
Us biosimilars market opportunity & clinical pipeline analysis
Us biosimilars market opportunity & clinical pipeline analysisUs biosimilars market opportunity & clinical pipeline analysis
Us biosimilars market opportunity & clinical pipeline analysis
 
Download Us biosimilars market opportunity & clinical pipeline analysis
Download Us biosimilars market opportunity & clinical pipeline analysisDownload Us biosimilars market opportunity & clinical pipeline analysis
Download Us biosimilars market opportunity & clinical pipeline analysis
 
Orphan Drug Report
Orphan Drug ReportOrphan Drug Report
Orphan Drug Report
 
Global Nutraceuticals Market | Functional Food | Industry Analysis, Size and ...
Global Nutraceuticals Market | Functional Food | Industry Analysis, Size and ...Global Nutraceuticals Market | Functional Food | Industry Analysis, Size and ...
Global Nutraceuticals Market | Functional Food | Industry Analysis, Size and ...
 
The Clinical Trials Business
The Clinical Trials BusinessThe Clinical Trials Business
The Clinical Trials Business
 
2014 Profile: Biopharmaceutical Research Industry
2014 Profile: Biopharmaceutical Research Industry2014 Profile: Biopharmaceutical Research Industry
2014 Profile: Biopharmaceutical Research Industry
 
Group4padgett&becoatm6a1
Group4padgett&becoatm6a1Group4padgett&becoatm6a1
Group4padgett&becoatm6a1
 
Group4 padgett&becoatm6a1
Group4 padgett&becoatm6a1Group4 padgett&becoatm6a1
Group4 padgett&becoatm6a1
 
New Drug Approval Process .pptx
 New Drug Approval Process .pptx New Drug Approval Process .pptx
New Drug Approval Process .pptx
 
Challenges for drug development jsr slides aug 2013
Challenges for drug development jsr slides aug 2013Challenges for drug development jsr slides aug 2013
Challenges for drug development jsr slides aug 2013
 
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
 

Next-Generation Superfruits

  • 1. Next-Generation Superfruits Report Details: Published:September 2012 No. of Pages: 90 Price: Single User License – US$2875 This report examines the emerging market of superfruits within the global food and drinks market, analyzing data from four metrics: product launches, patent applications, health claim applications, and clinical trial data. This will enable manufacturers to assess the emerging trends and growth opportunities within the superfruit food and drinks landscape. Features and benefits •Use patent application data to see which superfruits are provoking the most interest in terms of research and what is being deemed patentable. •Use product launch data to identify the target areas for existing superfruit-based products. Understand the product breakdown by category. •Assess EFSA's opinions and understand what types of claims are being made about which superfruits. •Identify three up-and-coming superfruits as “ones to watch” in the future. Highlights Blueberry and pomegranate are the most popular superfruits in new food and drink launches. But novel fruits are gaining ground, with chokeberry, jujube, and seabuckthorn being notable examples. Over 400 new food and drink products containing seabuckthorn were launched in 2009–12, the majority of which hit shelves in Russia, Germany, and France. A high proportion of health claims involving superfruits have been specifically about antioxidants, with over one in 10 claims submitted to EFSA addressing antioxidant properties. Although many superfruit ingredients have been lauded for their cellular protection properties, only acerola is associated with an endorsed health claim by EFSA. According to the Cochrane Library, a significant 63% of clinical trials undertaken on superfruits in the period 2009 to 2012 were able to establish a cause and effect relationship. This should prompt further testing in future to establish the positive roles superfruits play in managing certain health conditions. Your key questions answered •What are the more unusual superfruits that have potential to be successfully applied to food and drinks products? •What health claims are being made about superfruits and how will these impact food and drinks players?
  • 2. •What clinical trials are being undertaken on superfruits and how can these be useful to food and drinks companies? •What patent applications have recently been filed on these superfruits and what will be the impact on their FMCG usage? •How will regulations impact the sale of these superfruits in global markets? Get your copy of this report @ http://www.reportsnreports.com/reports/195677-next-generation-superfruits.html Major points covered in Table of Contents of this report include Table of Contents About the author Disclaimer EXECUTIVE SUMMARY The product launch landscape The patent landscape The health claims landscape The clinical trials landscape Introduction What is this report about? Defining superfruits Methodology Report structure The product launch landscape Summary Introduction Leading superfruit ingredients in NPD Novel superfruit ingredients in NPD Chokeberry Jujube Seabuckthorn New product category analysis Claims analysis in new product launches Anti-infective Cardiovascular Digestive health Metabolic disorders Conclusions The patent landscape Summary Introduction Superfruit patent applications
  • 3. Tier one Tier two Tier three Patents by therapeutic health area Conclusions The health claims landscape Summary Introduction EFSA now has stricter controls on functional food claims Analysis of superfruit health claims from EFSA Scientific opinion Leading therapeutic areas of claim submissions Conclusions The clinical trials landscape Summary Introduction Existing clinical evidence for superfruits Most popular therapeutic areas for superfruit clinical trials Conclusions Conclusions Key superfruits Current market landscape summary Key targeted therapeutic areas Superfruits: ones to watch Mangosteen Papaya Seabuckthorn Conclusions Appendix Methodology Glossary/abbreviations Bibliography/references List of Tables Table: Superfruits covered in this report Table: Leading superfruits in new food and drinks, by percentage of superfruit launches, 2009–12 Table: Leading superfruits in new food and drinks, by percentage of the 30 superfruits analyzed in this report, 2009–12 Table: Targeted therapeutic areas by health claims on new product launches (%), 2009–12 Table: Patent applications in 2010 related to tier one superfruits Table: Acerola related patent applications, 2005–11 Table: Tier three superfruits: No patent applications related to food and drink Table: Digestive health and metabolic therapeutic areas related to superfruit patent applications
  • 4. Table: EFSA negative opinions for superfruit health claims, 2011 Table: Targeted therapeutic areas by health claims submitted to EFSA, 2009–12 Table: Superfruit status by clinical trials, 2009–12 Table: Targeted health areas of clinical trials, 2009–12 Table: Future opportunities in superfruits as indicated by successful clinical trials, 2009–12 Table: Patent applications for mangosteen, in food and drinks, 2005–12 Table: Health claim applications for mangosteen, 2009–12 Table: Clinical trials involving mangosteen, 2009–10 Table: Patent applications for papaya, 2001–12 Table: Health claim submissions for papaya, 2009–12 Table: Patent applications for seabuckthorn, 2000–12 Table: Health claim submissions to EFSA for seabuckthorn, 2009–12 Table: Clinical trials for seabuckthorn Table: Alternative names for superfruits List of Figures Figure: Total oxygen radical absorbance capacity value, raw fruits Figure: "High antioxidants" is a leading health claim found on US food products, and has a strong association with superfruits Figure: Proportion of US consumers that say that they are familiar with specific superfruits Figure: Leading countries for superfruit food and drink launches by SKU, 2010–12 Figure: A selection of blueberry-flavored products that have recently been launched Figure: A selection of pomegranate-flavored products that have recently been launched Figure: Food and drink launches containing chokeberry, 2009–12 Figure: Chokeberry/aronia-flavored healthy indulgent foods Figure: Products containing jujube Figure: Food and drink launches containing jujube, 2009–12 Figure: A selection of seabuckthorn-flavored products Figure: Food and drink launches containing seabuckthorn, 2009–12 Figure: New product launches by industry and category (%), 2011 Figure: New product launches by industry and category (%), 2011 Figure: Superfruit tea and coffee launches Figure: Raspberry hazelnut vinaigrette and superfruit berry varieties of Wish Bone salad dressing Figure: Percentage of consumers who frequently consume products described as the following Figure: A word cloud showing superfruit patent applications: the bigger the word, the more patents the superfruit has had Figure: Tier one superfruits: number of patent applications related to food and drink Figure: Tier one superfruit patent activity by year, 2005–11 Figure: Tier two superfruits: Number of patent applications related to food and drink Figure: Tier two superfruit patent activity by year, 2005–11 Figure: Patents by therapeutic area Figure: Health claims related to superfruits submitted to EFSA, 2009–12 Figure: Classification of superfruits by number of health claims submitted to EFSA, 2009–12
  • 5. Figure: Targeted therapeutic areas by health claim submissions, 2009–12 Figure: Superfruits supported by clinical trials data (%), 2009–12 Figure: Targeted therapeutic areas of clinical trials (%) ,2009–12 Figure: Future of superfruits as indicated by manufacturing, research, health claims, and patents Figure: The future of the leading superfruits as indicated by health claim, patent and clinical trial activity Figure: Superfruits by health claim submissions and clinical data, 2009–12 Figure: Superfruits by patent applications and to clinical trial data Figure: Superfruits by manufacturer interest and clinical data Figure: Key targeted therapeutic areas by superfruits Figure: Mangosteen NPD activity and patent, health claim, and clinical trial submissions Figure: Top five categories for new mangosteen food and drink launches, 2009–12 Figure: Selection of mangosteen-flavored juice and ice cream Figure: Leading countries for mangosteen food and drink launches by SKU, 2009–12 Figure: Papaya NPD activity and patent, health claim, and clinical trial submissions Figure: Leading countries for papaya food and drink launches by SKU, 2009–12 Figure: Top five categories for new papaya food and drink launches, 2009–12 Figure: A selection of juices and fruit products containing papaya Figure: Seabuckthorn NPD activity and patent, health claim, and clinical trial submissions Figure: Leading countries for seabuckthorn food and drink launches by SKU, 2009–12 Figure: Top five categories for new seabuckthorn food and drink launches, 2009–12 Figure: Selection of seabuckthorn jams and jellies, including Mondo Berry Contact: sales@reportsandreports.com for more information.